Cuprina Holdings (Cayman) LTD (CUPR) stock
CUPRNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$1.69+0.01 (+0.60%)
Close on Nov 17, 2026Market cap $12.45MP/E –Yield –
Cuprina Holdings (Cayman) r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was 226.88K SGD, down 6.0% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 226.88K SGD | -6.0% |
| FY2024 | Dec 31, 2024 | 241.36K SGD | +43.9% |
| FY2023 | Dec 31, 2023 | 167.73K SGD | -42.7% |
| FY2022 | Dec 31, 2022 | 292.88K SGD | – |
See a number that looks wrong?